Company / Cost of Revenue
Bio Essence Corp Cost of Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$469.2K
FY2025
5-year range
$91.8K / $469.2K
FY2021-FY2025
Trend
+339.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue changed +339% YoY in FY2025, a notable deviation from the 4-year average annual change of +123%.
Based on SEC 10-K filings.
$469,153 in FY2025 with a 3-year CAGR of +17.0%.
Increased from $274,060 to $469,153 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +17.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +17.0%, indicating consistent growth.
- In FY2025, cost of revenue increased 339.0% year-over-year.
- Lowest cost of revenue in the period was in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 9/9 (strong financial health signals)
- Altman Z-Score -11.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $469.2K | +339.0% |
| FY2024 | $106.9K | -61.0% |
| FY2023 | $274.1K | -6.5% |
| FY2022 | $293.3K | +219.6% |
| FY2021 | $91.8K | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 29, 2026